Skip to content

Clinical trials

Terminated Phase 3 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Terminated Country / region: China Clear all

260 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20054
200713
200812
20099
201010
20118
20128
20137
20148
20155
201610
20179
201827
201920
202028
202139
202223
202313
20247

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated260

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche19
Novartis Pharmaceuticals19
Pfizer12
Sanofi12
Sun Yat-sen University10
GlaxoSmithKline8
Jiangsu HengRui Medicine Co., Ltd.8
Merck Sharp & Dohme LLC8
AstraZeneca7
Bayer7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung22
Breast Neoplasms15
Diabetes Mellitus, Type 29
Carcinoma, Hepatocellular7
Colorectal Neoplasms7
Neoplasms7
Alzheimer Disease5
Cardiovascular Diseases5
Lupus Erythematosus, Systemic5
Renal Insufficiency, Chronic5

Trials

Showing 1 to 25 of 260. Each trial links to its page on Pharma Observatory.

160 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.